Your browser doesn't support javascript.
loading
The intestinal microbiome of infants with cow's milk-induced FPIES is enriched in taxa and genes of enterobacteria.
Castro, Ana M; Sabater, Carlos; Navarro, Sandra; Rodriguez, Silvia; Molinos, Cristina; Jiménez, Santiago; Claver, Angela; Espin, Beatriz; Domínguez, Gloria; Coronel, Cristóbal; Toyos, Paula; Gutiérrez-Díaz, Isabel; Sariego, Lydia; Fernández, Porfirio; Perez, David; Margolles, Abelardo; Díaz, Juan J; Delgado, Susana.
Afiliación
  • Castro AM; MicroHealth Group, Instituto de Productos Lácteos de Asturias-Consejo Superior de Investigaciones Científicas (IPLA-CSIC)/Instituto Biosanitario del Principado de Asturias (ISPA), Villaviciosa, Asturias, Spain.
  • Sabater C; MicroHealth Group, Instituto de Productos Lácteos de Asturias-Consejo Superior de Investigaciones Científicas (IPLA-CSIC)/Instituto Biosanitario del Principado de Asturias (ISPA), Villaviciosa, Asturias, Spain.
  • Navarro S; Primary Care Center Teatinos-Corredoria, Oviedo, Asturias, Spain.
  • Rodriguez S; Paediatrics Service, Hospital Universitario de San Agustín, Avilés, Asturias, Spain.
  • Molinos C; Paediatrics Department, Hospital Universitario de Cabueñes, Gijón, Asturias, Spain.
  • Jiménez S; Paediatric Group, ISPA, Oviedo, Asturias, Spain.
  • Claver A; Allergology, Hospital Universitario Dexeus, Barcelona, Spain.
  • Espin B; Paediatric Gastroenterology Unit, Hospital Universitario Virgen del Rocío de Sevilla, Sevilla, Spain.
  • Domínguez G; Gastroenterology and Nutrition Section, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
  • Coronel C; Primary Care Center Amante Laffón, Sevilla, Spain.
  • Toyos P; Paediatric Group, ISPA, Oviedo, Asturias, Spain.
  • Gutiérrez-Díaz I; MicroHealth Group, Instituto de Productos Lácteos de Asturias-Consejo Superior de Investigaciones Científicas (IPLA-CSIC)/Instituto Biosanitario del Principado de Asturias (ISPA), Villaviciosa, Asturias, Spain.
  • Sariego L; MicroHealth Group, Instituto de Productos Lácteos de Asturias-Consejo Superior de Investigaciones Científicas (IPLA-CSIC)/Instituto Biosanitario del Principado de Asturias (ISPA), Villaviciosa, Asturias, Spain.
  • Fernández P; Paediatric Group, ISPA, Oviedo, Asturias, Spain.
  • Perez D; Paediatrics Service, Hospital Universitario de San Agustín, Avilés, Asturias, Spain.
  • Margolles A; MicroHealth Group, Instituto de Productos Lácteos de Asturias-Consejo Superior de Investigaciones Científicas (IPLA-CSIC)/Instituto Biosanitario del Principado de Asturias (ISPA), Villaviciosa, Asturias, Spain.
  • Díaz JJ; Paediatric Group, ISPA, Oviedo, Asturias, Spain.
  • Delgado S; MicroHealth Group, Instituto de Productos Lácteos de Asturias-Consejo Superior de Investigaciones Científicas (IPLA-CSIC)/Instituto Biosanitario del Principado de Asturias (ISPA), Villaviciosa, Asturias, Spain.
Article en En | MEDLINE | ID: mdl-39175183
ABSTRACT

OBJECTIVES:

Food protein-induced enterocolitis syndrome (FPIES) is a severe type of non-IgE (immunoglobulin E)-mediated (NIM) food allergy, with cow's milk (CM) being the most common offending food. The relationship between the gut microbiota and its metabolites with the inflammatory process in infants with CM FPIES is unknown, although evidence suggests a microbial dysbiosis in NIM patients. This study was performed to contribute to the knowledge of the interaction between the gut microbiota and its derived metabolites with the local immune system in feces of infants with CM FPIES at diagnosis.

METHODS:

Twelve infants with CM FPIES and a matched healthy control group were recruited and the gut microbiota was investigated by 16S amplicon and shotgun sequencing. Fatty acids (FAs) were measured by gas chromatography, while immune factors were determined by enzyme-linked immunosorbent assay and Luminex technology.

RESULTS:

A specific pattern of microbiota in the gut of CM FPIES patients was found, characterized by a high abundance of enterobacteria. Also, an intense excretion of FAs in the feces of these infants was observed. Furthermore, correlations were found between fecal bifidobacteria and immune factors.

CONCLUSION:

These fecal determinations may be useful to gain insight into the pathophysiology of this syndrome and should be taken in consideration for future studies of FPIES patients.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Pediatr Gastroenterol Nutr Año: 2024 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Pediatr Gastroenterol Nutr Año: 2024 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos